Effient (prasugrel)
July 21, 2009
December 2008 A U.S. FDA advisory panel reviewed Eli Lilly's and
Daiichi Sankyo's blood-clot preventer prasugrel, adding a new hurdle
for approval of the potential blockbuster medicine.
THIS WEBSITE TALKS ABOUT THE SIDE EFFECTS AND THE POTENTIAL HEALTH BENEFITS OF HERBS, SUPPLEMENTS,